These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 26073325)

  • 21. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy.
    Ohira M; Ohdan H; Mitsuta H; Ishiyama K; Tanaka Y; Igarashi Y; Asahara T
    Transplantation; 2006 Dec; 82(12):1712-9. PubMed ID: 17198265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction.
    Yang Y; Han Q; Hou Z; Zhang C; Tian Z; Zhang J
    Cell Mol Immunol; 2017 May; 14(5):465-475. PubMed ID: 27238466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells.
    Tsunematsu H; Tatsumi T; Kohga K; Yamamoto M; Aketa H; Miyagi T; Hosui A; Hiramatsu N; Kanto T; Hayashi N; Takehara T
    Int J Cancer; 2012 Jan; 130(2):356-64. PubMed ID: 21351090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade.
    Bozward AG; Warricker F; Oo YH; Khakoo SI
    Front Immunol; 2021; 12():643310. PubMed ID: 33995362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection-Related Advanced Hepatocellular Carcinoma: A Literature Review.
    Li B; Yan C; Zhu J; Chen X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Jiang W; Fang W
    Front Immunol; 2020; 11():1037. PubMed ID: 32547550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma.
    Shin SK; Oh S; Chun SK; Ahn MJ; Lee SM; Kim K; Kang H; Lee J; Shin SP; Lee J; Jung YK
    J Gastroenterol Hepatol; 2024 Sep; 39(9):1717-1727. PubMed ID: 38800890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interactions between major immune effector cells and Hepatocellular Carcinoma: A systematic review.
    Schoenberg MB; Li X; Li X; Han Y; Börner N; Koch D; Guba MO; Werner J; Bazhin AV
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108220. PubMed ID: 34673334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-21 reinvigorates exhausted natural killer cells in patients with HBV-associated hepatocellular carcinoma in STAT1-depedent pathway.
    Jin Y; Sun Z; Geng J; Yang L; Song Z; Song H; Wang J; Tang J
    Int Immunopharmacol; 2019 May; 70():1-8. PubMed ID: 30780004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MICA SNPs and the NKG2D system in virus-induced HCC.
    Goto K; Kato N
    J Gastroenterol; 2015 Mar; 50(3):261-72. PubMed ID: 25270965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adaptive Subsets Limit the Anti-Tumoral NK-Cell Activity in Hepatocellular Carcinoma.
    Rennert C; Tauber C; Fehrenbach P; Heim K; Bettinger D; Sogukpinar Ö; Schuch A; Zecher BF; Bengsch B; Lang SA; Bronsert P; Björkström NK; Fichtner-Feigl S; Schultheiss M; Thimme R; Hofmann M
    Cells; 2021 Jun; 10(6):. PubMed ID: 34199483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical-scale isolation of interleukin-2-stimulated liver natural killer cells for treatment of liver transplantation with hepatocellular carcinoma.
    Ohira M; Nishida S; Tryphonopoulos P; Tekin A; Selvaggi G; Moon J; Levi D; Ricordi C; Ishiyama K; Tanaka Y; Ohdan H; Tzakis AG
    Cell Transplant; 2012; 21(7):1397-406. PubMed ID: 22469170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel natural killer cell-mediated cancer immunotherapeutic activity of anisomycin against hepatocellular carcinoma cells.
    Kim M; Lee SJ; Shin S; Park KS; Park SY; Lee CH
    Sci Rep; 2018 Jul; 8(1):10668. PubMed ID: 30006566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma.
    Zhang PF; Gao C; Huang XY; Lu JC; Guo XJ; Shi GM; Cai JB; Ke AW
    Mol Cancer; 2020 Jun; 19(1):110. PubMed ID: 32593303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on the correlations between HBsAg and hepatitis C virus expression as well as fibrotic staging in hepatocellular carcinoma and pericarcinomatous tissues].
    Xuan SY; Xin YN; Chen H; Shi GJ; Sun Y; Zhang J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Feb; 27(2):157-60. PubMed ID: 16750000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Taste receptor T1R1/T1R3 promotes the tumoricidal activity of hepatic CD49a
    Liu S; Xu M; Zhu C; Zhao Q; Zhou F
    Eur J Immunol; 2018 Dec; 48(12):2031-2041. PubMed ID: 30259960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.
    Lee JJ; Kim PT; Fischer S; Fung S; Gallinger S; McGilvray I; Moulton CA; Wei AC; Greig PD; Cleary SP
    Ann Surg Oncol; 2014 Aug; 21(8):2708-16. PubMed ID: 24806113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B.
    Ju Y; Hou N; Meng J; Wang X; Zhang X; Zhao D; Liu Y; Zhu F; Zhang L; Sun W; Liang X; Gao L; Ma C
    J Hepatol; 2010 Mar; 52(3):322-9. PubMed ID: 20133006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma.
    Wang T; Sun F; Xie W; Tang M; He H; Jia X; Tian X; Wang M; Zhang J
    Cancer Lett; 2016 Mar; 372(2):166-78. PubMed ID: 26791237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions.
    Wu Y; Kuang DM; Pan WD; Wan YL; Lao XM; Wang D; Li XF; Zheng L
    Hepatology; 2013 Mar; 57(3):1107-16. PubMed ID: 23225218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.